Stock info Atossa Genetics | Filter  Basic-Info

Atossa Genetics

Atossa Genetics's headquarter is located in Seattle,. The core activities of Atossa Genetics are in the health care eq. & services sector. Dr. Steven C. Quay M.D., Ph.D., FCAP is leading the company as CEO. The CFO of the company is Mr. Kyle Guse Esq., CPA,. The global health care companies gained around 102 percent over the period 2006-2016. As from 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.

The past year was a good investment year for Atossa Genetics investors

The stock gained over the past 12 months at around 295 percent. Over the period 2011-2016 the stock lost a modest 0 percent. Atossa Genetics's revenues between 2011 and 2015 were very fluctuating and moved between 0,48 million dollars and 0 million dollars. Atossa Genetics's net results between 2011 and 2015 were very fluctuating and moved between -3,44 million dollars and -12,76 million dollars.

The American company didn't pay out any dividends (in the past 5 years).

Atossa Genetics financed with a quite low debt position

At the end of 2015 the health care company's balance sheet was worth 6,24 million dollars. The total debt was around 2,5 million dollars. This is 40,06 percent of the total balance sheet. As per the end of 2015 Atossa Genetics's price/earnings-ratio equaled -3. So investors paid for 1 stock -3 times the earnings per share of 2015. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 8,81 million dollars. At the end of 2015 around 28,43 million stocks were listed.

On this page you can find all Atossa Genetics's financial reports. More information about Atossa Genetics can be found it's website. .